Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


What's in a color? GSK wins injunction against Sandoz

This article was originally published in Scrip

Executive Summary

GlaxoSmithKline has won the first round in a battle with Novartis's generics arm Sandoz over the color purple. A German court has handed down a preliminary injunction blocking Sandoz from selling its salmeterol/fluticasone product, AirFluSal Forspiro. The injunction is related to the fact that the colors of the AirFluSal Forspiro inhaler and GSK's Advair (salmeterol/fluticasone) are similar.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts